Rocco M. Ferrandino, MD, MSCR; Joshua Barlow, MD; Brandon Gold, MD; et al.
This diagnostic study assesses the performance metrics of tumor tissue–modified human papillomavirus (HPV) DNA testing for diagnosing oropharyngeal squamous cell carcinoma in patients with a lateral neck mass.